Tanabe Research Labs Enters R&D Partnership with Anaphore to Develop Novel Protein Pharmaceuticals For Autoimmune Disorders

Tanabe Research Labs Enters R&D Partnership with Anaphore to Develop Novel Protein Pharmaceuticals For Autoimmune Disorders

December 13th, 2010 San Diego, CA – (December 13th, 2010) – Tanabe Research Laboratories U.S.A. Inc., (TRL) announced today that it has entered into a partnership with Anaphore Inc. for the research and preclinical development of novel protein therapies for autoimmune diseases based on Anaphore’s proprietary Atrimerâ„¢ technology. TRL and Anaphore will generate novel trivalent […]

Read More »